More than six million Americans age 65 and up are living with Alzheimer’s including more than 35,000 Nebraska residents.

Leqembi's subcutaneous dosing allows Alzheimer's patients to administer weekly treatment at home in 15 seconds. Get Real-Time ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Levels were found to drop gradually, from women with no signs of memory ... Supports New Blood-Based Biomarker to Detect Early Brain Changes Leading to Cognitive Impairment and Dementia Dec ...

Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

A new study found that dementia cases in the United States are projected to double from more than 500,000 in 2020 to about 1 million by 2050.

Groundbreaking research unveils potential link between cytomegalovirus and Alzheimer's disease, offering new hope for ...

Older studies estimated a lower risk of dementia. According to new research, the number of people living with the disease in ...

As the American population ages, a new study finds the average lifetime risk of dementia for adults over 55 is around 42 ...

Alzheimer's disease is the most common type of dementia. Here, we break down what to know about this disease, including: What ...

Understanding dementia and Alzheimer’s disease is essential for maintaining a proactive approach to our well-being.

A predictive tool for determining the age at which individuals may develop mild cognitive impairment (MCI) or Alzheimer's ...